Fecal Microbiota Transplantation for IBS

Recruiting now · Phase 2

Conditions studied: Irritable Bowel Syndrome, Diarrhea

In brief

The purpose of this study is to learn the efficacy and safety of fecal microbiota transplantation (FMT) using stool from a donor with low proteolytic activity and containing the bacteria Alistipes putredinis in patients with irritable bowel syndrome (IBS) and high proteolytic activity. Proteolytic activity is the breakdown of proteins into smaller polypeptides or amino acids.

Key facts

Study ID
NCT05776914
Run by
Madhusudan (Madhu) Grover, MBBS
People needed
43
Starts
2024-04-15
Expected to finish
2027-06-26
Last updated by the study team
2026-05-08

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.